Biochemical methods for predicting the occurrence of tardive dyskinesia.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000378:metabolism*; D004409:Dyskinesia, Drug-Induced / Q000378:metabolism*; D006220:Haloperidol / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism*; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D011955:Receptors, Drug / Q000378:metabolism
D014150:Antipsychotic Agents; D010648:Phenylacetates; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D001285:Atropine; D000661:Amphetamine; D006220:Haloperidol; D006719:Homovanillic Acid